Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

MiMedx Group, Inc. is an advanced wound care and an emerging therapeutic biologics company. The company is headquartered in Marietta, Georgia and currently employs 690 full-time employees. The firm`s Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories. Its biomaterial platform technologies include AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn, and CollaFix. AmnioFix and EpiFix are its tissue technologies processed from human amniotic membrane derived from donated placentas. OrthoFlo is amniotic fluid-derived allograft for homologous use. Physio is a bone grafting material consists of bone tissue with no added carrier. CollaFix, its new brand, is its collagen fiber technology designed to mimic the natural composition, structure and mechanical properties of musculoskeletal tissues in order to augment their repair.
Website: mimedx.com



Growth: Good revenue growth rate 35.7%, there is acceleration compared to average historical growth rates 14.9%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is positive, +11.2%. On average the margin is improving unsteadily. Gross margin is high, +83.5%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 40% of quarters (showing a gain of $0 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 6.9% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 67.2% higher than minimum and 46.3% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.1x by EV / Sales multiple , the company can be 87.5% undervalued

Key Financials (Download financials)

Ticker: MDXG
Share price, USD:  (0.0%)5.25
year average price 6.85  


year start price 8.40 2025-02-15

max close price 8.41 2025-02-28

min close price 5.25 2026-01-26

current price 5.25 2026-02-14
Common stocks: 148 035 283

Dividend Yield:  0.0%
FCF Yield LTM: 6.9%
EV / LTM EBITDA: 14.8x
EV / EBITDA annualized: 7.4x
Last revenue growth (y/y):  +35.7%
Last growth of EBITDA (y/y):  +100.0%
Historical revenue growth:  +14.9%
Historical growth of EBITDA:  +77.0%
EV / Sales: 1.7x
Margin (EBITDA LTM / Revenue): 11.2%
Fundamental value created in LTM:
Market Cap ($m): 777
Net Debt ($m): -124
EV (Enterprise Value): 653
Price to Book: 3.3x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-12-22globenewswire.com

MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel

2025-11-03globenewswire.com

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule

2025-07-30seekingalpha.com

MiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call Transcript

2025-07-30zacks.com

MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates

2025-07-15globenewswire.com

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

2025-07-09zacks.com

Strength Seen in MiMedx (MDXG): Can Its 8.0% Jump Turn into More Strength?

2025-04-30seekingalpha.com

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

2025-04-30zacks.com

MiMedx (MDXG) Q1 Earnings Match Estimates

2025-02-26seekingalpha.com

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript

2025-02-26zacks.com

MiMedx (MDXG) Q4 Earnings Meet Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-29 2025-07-30 2024-10-30 2024-07-31 2024-04-30 2023-10-30 2023-08-01 2023-05-02 2022-11-02
acceptedDate 2025-10-29 16:00:50 2025-07-30 16:01:02 2025-02-26 16:00:35 2024-10-30 16:01:55 2024-07-31 16:00:39 2024-04-30 16:04:03 2024-02-28 16:02:35 2023-10-30 16:07:41 2023-08-01 16:04:50 2023-05-02 16:01:05 2023-05-01 16:36:20 2022-11-02 16:15:47 2022-02-28 17:11:13 2021-03-08 17:27:53
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 114M 99M 349M 84M 87M 85M 321M 82M 81M 72M 268M 68M 242M 248M
costOfRevenue 19M 19M 60M 15M 15M 13M 55M 15M 14M 12M 48M 12M 40M 39M
grossProfit 95M 80M 289M 69M 72M 72M 267M 67M 68M 59M 220M 56M 202M 209M
grossProfitRatio 0.835 0.811 0.818 0.827 0.844 0.819 0.833 0.827 0.82
researchAndDevelopmentExpenses 4M 3M 12M 3M 3M 3M 13M 3M 8M 6M 13M 6M 10M 12M
generalAndAdministrativeExpenses 0 16M 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 48M 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 69M 64M 216M 54M 55M 55M 216M 53M 52M 52M 221M 53M 195M 240M
otherExpenses 112 000 100 000 1M 1M 10M -311 000 762 000 -11 000 -32 000 4M 701 000 3M 5M 2M
operatingExpenses 73M 68M 230M 58M 49M 58M 230M 56M 62M 63M 234M 63M 209M 254M
costAndExpenses 92M 86M 290M 73M 64M 71M 284M 71M 75M 75M 283M 75M 249M 294M
interestIncome 0 1M 0 278 000 0 0 0 2M 2M 0 0 0 0 0
interestExpense 785 000 475 000 1M 0 3000 2M 6M 2M 2M -2M 5M 1M 5M 8M
depreciationAndAmortization 5M 3M 6M 773 000 767 000 747 000 3M 843 000 877 000 904 000 4M 886 000 5M 7M
ebitda 29M 16M 65M 12M 23M 14M 41M 12M 7M -2M -11M -6M -2M -38M
ebitdaratio 0.254 0.157 0.145 0.278 0.165 0.145 0.083 -0.035 -0.092
operatingIncome 22M 12M 59M 11M 23M 13M 37M 11M 3M -3M -15M -7M -7M -45M
operatingIncomeRatio 0.195 0.125 0.133 0.269 0.156 0.132 0.034 -0.047 -0.105
totalOtherIncomeExpensesNet 659 000 637 000 -2M 257 000 -234 000 -2M -6M -219 000 -3M -2M -5M -1M -5M -16M
incomeBeforeTax 23M 13M 57M 11M 23M 11M 31M 9M 1M -5M -20M -8M -12M -62M
incomeBeforeTaxRatio 0.201 0.132 0.136 0.266 0.135 0.112 0.014 -0.069 -0.124
incomeTaxExpense 6M 3M 15M 4M 6M 2M -37M 591 000 -74 000 51 000 206 000 53 000 247 000 -12M
netIncome 17M 10M 42M 8M 18M 9M 67M 7M 1M -5M -30M -8M -12M -49M
netIncomeRatio 0.147 0.098 0.096 0.202 0.109 0.083 0.015 -0.07 -0.124
eps 0.11 0.065 0.29 0.055 0.12 0.063 0.48 0.058 0.01 -0.044 -0.27 -0.074 -0.093 -0.46
epsdiluted 0.11 0.064 0.055 0.12 0.062 0.057 0.01 -0.044 -0.074
weightedAverageShsOut 148M 148M 147M 147M 147M 146M 116M 116M 116M 114M 113M 113M 110M 108M
weightedAverageShsOutDil 150M 149M 149M 148M 149M 150M 146M 119M 116M 114M 113M 113M 110M 108M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-26 2024-02-28 2023-05-01 2022-02-28 2021-03-08
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -1M -6M -5M -5M -8M
ebit 59M 37M -15M -7M -44M
nonOperatingIncomeExcludingInterest -446 000 0 0 23 000 -1M
netIncomeFromContinuingOperations 42M 67M -20M -12M -49M
netIncomeFromDiscontinuedOperations 421 000 0 -10M 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 42M 56M -37M -18M -49M
epsDiluted 0.28 0.38 -0.27 -0.093 -0.46

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-29 2025-07-30 2024-10-30 2024-07-31 2024-04-30 2023-10-30 2023-08-01 2023-05-02 2022-11-02
acceptedDate 2025-10-29 16:00:50 2025-07-30 16:01:02 2025-02-26 16:00:35 2024-10-30 16:01:55 2024-07-31 16:00:39 2024-04-30 16:04:03 2024-02-28 16:02:35 2023-10-30 16:07:41 2023-08-01 16:04:50 2023-05-02 16:01:05 2023-05-01 16:36:20 2022-11-02 16:15:47 2022-02-28 17:11:13 2021-03-08 17:27:53
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 142M 119M 104M 89M 69M 48M 82M 81M 69M 61M 66M 73M 87M 96M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 142M 119M 104M 89M 69M 48M 82M 81M 69M 61M 66M 73M 87M 96M
netReceivables 78M 69M 56M 54M 53M 57M 54M 49M 49M 45M 43M 42M 40M 35M
inventory 27M 25M 24M 24M 25M 24M 21M 19M 17M 15M 13M 14M 11M 10M
otherCurrentAssets 7M 8M 3M 5M 7M 9M 2M 2M 3M 2M 5M 7M 4M 13M
totalCurrentAssets 254M 221M 192M 172M 154M 139M 164M 155M 141M 132M 134M 136M 149M 161M
propertyPlantEquipmentNet 10M 10M 12M 9M 10M 11M 9M 10M 10M 11M 11M 12M 14M 15M
goodwill 19M 19M 19M 19M 19M 19M 19M 19M 19M 20M 19M 20M 20M 20M
intangibleAssets 11M 12M 12M 11M 12M 13M 5M 5M 6M 6M 6M 5M 5M 6M
goodwillAndIntangibleAssets 31M 31M 31M 31M 31M 32M 25M 25M 25M 26M 25M 25M 25M 26M
longTermInvestments 0 0 0 0 -1 -39M 0 0 0 0 0 0 0 0
taxAssets 22M 27M 28M 31M 33M 39M 41M 0 0 0 0 0 0 0
otherNonCurrentAssets 3M 989 999 1M 1M 1M 40M 205 000 149 000 146 000 147 000 683 000 150 000 186 000 375 000
totalNonCurrentAssets 65M 70M 72M 72M 76M 83M 75M 35M 35M 36M 37M 37M 39M 41M
otherAssets 0 0 0 0 1 0 0 0 0 0 0 0 0 0
totalAssets 319M 291M 264M 244M 230M 222M 239M 189M 176M 168M 171M 173M 188M 202M
accountPayables 11M 8M 7M 7M 8M 10M 9M 9M 8M 8M 8M 9M 7M 9M
shortTermDebt 1M 1M 1 000 000 1 000 000 1 000 000 1 000 000 0 0 0 0 1M 0 0 0
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherCurrentLiabilities 45M 41M 25M 34M 31M 32M 15M 34M 36M 33M 13M 37M 4M 26M
totalCurrentLiabilities 58M 50M 46M 42M 40M 42M 46M 44M 44M 41M 44M 46M 42M 59M
longTermDebt 17M 17M 18M 18M 18M 18M 48M 49M 49M 49M 49M 48M 48M 48M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 6M 7M 3M 3M 4M 5M 2M 95M 96M 97M 2M 45M 951 000 795 000
totalNonCurrentLiabilities 22M 24M 25M 21M 22M 24M 50M 144M 145M 145M 53M 54M 53M 51M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 0 6M 0 0 0 0 4M 0 0 2M 0 5M 4M
totalLiabilities 80M 74M 71M 63M 62M 66M 96M 188M 189M 186M 97M 100M 95M 111M
preferredStock 0 0 0 0 0 0 0 92M 92M 92M 92M 92M 92M 92M
commonStock 148 000 148 000 147 000 147 000 147 000 148 000 146 000 116 000 116 000 115 000 114 000 114 000 113 000 113 000
retainedEarnings -58M -75M -91M -99M -107M -124M -134M -187M -196M -197M -192M -191M -162M -151M
accumulatedOtherComprehensiveIncomeLoss 0 0 0 0 0 0 0 -92M -92M 0 0 0 0 -0
othertotalStockholdersEquity 297M 291M 280M 275M 280M 188M 183M 86M 172M
totalStockholdersEquity 239M 217M 193M 181M 168M 156M 143M 1M -13M -18M 75M 73M 93M 91M
totalEquity 239M 217M 193M 181M 168M 156M 143M 1M -13M -18M 75M 73M 93M 91M
totalLiabilitiesAndStockholdersEquity 319M 291M 244M 230M 222M 189M 176M 168M 173M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 319M 291M 264M 244M 230M 222M 239M 189M 176M 168M 171M 173M 188M 202M
totalInvestments 0 0 0 0 -1 -39M 0 0 0 0 0 0 0 0
totalDebt 18M 18M 25M 19M 19M 19M 48M 49M 49M 49M 52M 48M 53M 52M
netDebt -124M -100M -80M -70M -50M -29M -34M -32M -20M -13M -13M -25M -34M -44M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-26 2024-02-28 2023-05-01 2022-02-28 2021-03-08
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 56M 54M 43M 40M 35M
otherReceivables 0 0 0 0 0
prepaids 5M 6M 7M 6M 6M
totalPayables 9M 9M 8M 7M 9M
otherPayables 1M 0 0 0 0
accruedExpenses 9M 22M 21M 30M 23M
capitalLeaseObligationsCurrent 1M 0 0 1M 1M
capitalLeaseObligationsNonCurrent 5M 0 2M 4M 3M
treasuryStock 0 0 0 -4M -7M
additionalPaidInCapital 284M 276M 174M 166M 159M
otherTotalStockholdersEquity 0 0 0 -0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG MDXG
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-29 2025-07-30 2024-10-30 2024-07-31 2024-04-30 2023-10-30 2023-08-01 2023-05-02 2022-11-02
acceptedDate 2025-10-29 16:00:50 2025-07-30 16:01:02 2025-02-26 16:00:35 2024-10-30 16:01:55 2024-07-31 16:00:39 2024-04-30 16:04:03 2024-02-28 16:02:35 2023-10-30 16:07:41 2023-08-01 16:04:50 2023-05-02 16:01:05 2023-05-01 16:36:20 2022-11-02 16:15:47 2022-02-28 17:11:13 2021-03-08 17:27:53
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 17M 10M 42M 8M 18M 9M 67M 9M 1M -5M -20M -8M -12M -49M
depreciationAndAmortization 5M 3M 6M 2M 767 000 747 000 3M 843 000 877 000 904 000 4M 1M 5M 7M
deferredIncomeTax 6M 287 000 12M 3M 5M 2M -38M 292 000 3M 0 0 0 0 0
stockBasedCompensation 5M 5M 17M 4M 4M 4M 17M 4M 4M 4M 0 2M 14M 15M
changeInWorkingCapital -6M -4M -5M 9M 2M -12M -18M -2M -2M -5M -8M 5M -19M -16M
accountsReceivables -11M -7M -3M -953 000 4M -3M -12M -489 000 -5M -2M -6M -4M -11M -3M
inventory -2M -820 000 -2M 807 000 -663 000 -3M -8M -2M -2M -1M -2M -593 000 -1M -1M
accountsPayables 3M -668 000 -1M -1M -1M 283 000 783 000 453 000 893 000 -1M 839 000 648 000 -159 000 177 000
otherWorkingCapital 4M 5M 885 000 10M 321 000 -6M 876 000 566 000 4M -683 000 -1M 9M -7M -12M
otherNonCashItems 3M 791 000 -6M -4M -5M 12M -5M 456 000 469 000 417 000 6M 887 000 10M 12M
netCashProvidedByOperatingActivities 29M 14M 66M 22M 22M 5M 27M 13M 8M -4M -18M 959 000 -2M -30M
investmentsInPropertyPlantAndEquipment -192 000 0 -2M 2M -419 000 -1M -2M -649 000 -348 000 -677 000 -3M -374 000 -3M -4M
acquisitionsNet 0 0 -8M 0 0 0 0 0 0 0 24 000 0 0 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites -5M -887 000 -1M -486 000 -5M -21 000 0 0 -25 000
netCashUsedForInvestingActivites -5M -887 000 113 000 -905 000 -6M -649 000 -348 000 -677 000 -374 000
debtRepayment -250 000 -250 000 -251 000 -254 000 -31M -16 000 -16 000 -4000 -7000
commonStockIssued 0 0 0 0 766 000 386 000 20 000 0 0
commonStockRepurchased -83 000 -526 000 -3M -110 000 -349 000 -2M -10M 0 0 0 -1M 0 -5M -2M
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -524 000 -318 000 388 000 244 000 -1M 370 000 0 0 137 000
netCashUsedProvidedByFinancingActivities -857 000 -1M 27 000 -359 000 -32M 370 000 4000 -4000 130 000
effectOfForexChangesOnCash 0 0 0 0 0 0 0 0 -7M 0 0 0 0 0
netChangeInCash 23M 12M 22M 20M 21M -34M 16M 13M 7M -5M -21M 715 000 -9M 27M
cashAtEndOfPeriod 142M 119M 104M 89M 69M 48M 82M 81M 69M 61M 66M 73M 87M 96M
cashAtBeginningOfPeriod 119M 106M 82M 69M 48M 82M 66M 69M 61M 66M 87M 73M 96M 69M
operatingCashFlow 29M 14M 66M 22M 22M 5M 27M 13M 8M -4M -18M 959 000 -2M -30M
capitalExpenditure -4M 0 -2M 2M -419 000 -1M -2M -649 000 -348 000 -677 000 -2M -374 000 -3M -4M
freeCashFlow 25M 14M 65M 23M 21M 4M 25M 12M 7M -5M -19M 585 000 -5M -34M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-26 2024-02-28 2023-05-01 2022-02-28 2021-03-08
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 0 -177 000 -327 000
netCashProvidedByInvestingActivities -10M -2M -3M -3M -5M
netDebtIssuance -32M -52 000 -41 000 -38 000 -26M
longTermNetDebtIssuance -32M -52 000 -41 000 -38 000 -26M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -3M -9M -539 000 -5M 98M
netCommonStockIssuance -3M -9M -539 000 -5M -2M
commonStockIssuance 0 997 000 651 000 0 0
netPreferredStockIssuance 0 0 0 0 100M
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 159 000 0 0 1M -10M
netCashProvidedByFinancingActivities -34M -9M -580 000 -3M 62M
incomeTaxesPaid 3M 0 0 169 000 208 000
interestPaid 3M 0 0 4M 7M

Earning call transcript

2025 q3
2025-10-29 ET (fiscal 2025 q3)
2025 q2
2025-07-30 ET (fiscal 2025 q2)
2025 q1
2025-04-30 ET (fiscal 2025 q1)
2024 q4
2025-02-26 ET (fiscal 2024 q4)
2024 q3
2024-10-30 ET (fiscal 2024 q3)
2024 q2
2024-07-31 ET (fiscal 2024 q2)
2024 q1
2024-04-30 ET (fiscal 2024 q1)
2023 q4
2024-02-28 ET (fiscal 2023 q4)
2023 q3
2023-10-30 ET (fiscal 2023 q3)
2023 q2
2023-08-01 ET (fiscal 2023 q2)
2023 q1
2023-05-02 ET (fiscal 2023 q1)
2022 q4
2023-02-28 ET (fiscal 2022 q4)
2022 q3
2022-11-02 ET (fiscal 2022 q3)
2022 q2
2022-08-03 ET (fiscal 2022 q2)
2022 q1
2022-05-04 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-10-29 20:07 ET
MiMedx Group published news for 2025 q3
SEC form 8
2025-10-29 20:07 ET
MiMedx Group published news for 2025 q3
SEC form 8
2025-10-29 20:07 ET
MiMedx Group published news for 2025 q3
SEC form 8
2025-10-29 20:07 ET
MiMedx Group published news for 2025 q3
SEC form 10
2025-10-29 20:00 ET
MiMedx Group reported for 2025 q3
SEC form 8
2025-07-30 20:03 ET
MiMedx Group published news for 2025 q2
SEC form 8
2025-07-30 20:03 ET
MiMedx Group published news for 2025 q2
SEC form 8
2025-07-30 20:03 ET
MiMedx Group published news for 2025 q2
SEC form 8
2025-07-30 20:03 ET
MiMedx Group published news for 2025 q2
SEC form 10
2025-07-30 20:01 ET
MiMedx Group reported for 2025 q2
SEC form 10
2025-04-30 00:00 ET
MiMedx Group reported for 2025 q1
SEC form 8
2025-04-30 00:00 ET
MiMedx Group published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
MiMedx Group published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
MiMedx Group published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
MiMedx Group published news for 2025 q1
SEC form 10
2025-02-26 00:00 ET
MiMedx Group reported for 2024 q4
SEC form 8
2025-02-26 00:00 ET
MiMedx Group published news for 2024 q4
SEC form 8
2025-02-26 00:00 ET
MiMedx Group published news for 2024 q4
SEC form 8
2025-02-26 00:00 ET
MiMedx Group published news for 2024 q4
SEC form 8
2024-10-30 16:56 ET
MiMedx Group published news for 2024 q3
SEC form 8
2024-10-30 16:56 ET
MiMedx Group published news for 2024 q3
SEC form 8
2024-10-30 16:56 ET
MiMedx Group published news for 2024 q3
SEC form 8
2024-10-30 16:56 ET
MiMedx Group published news for 2024 q3
SEC form 10
2024-10-30 16:01 ET
MiMedx Group reported for 2024 q3
SEC form 10
2024-10-30 00:00 ET
MiMedx Group published news for 2024 q3
SEC form 8
2024-07-31 16:11 ET
MiMedx Group published news for 2024 q2
SEC form 8
2024-07-31 16:11 ET
MiMedx Group published news for 2024 q2
SEC form 8
2024-07-31 16:11 ET
MiMedx Group published news for 2024 q2
SEC form 8
2024-07-31 16:11 ET
MiMedx Group published news for 2024 q2
SEC form 10
2024-07-31 16:00 ET
MiMedx Group reported for 2024 q2
SEC form 10
2024-07-31 00:00 ET
MiMedx Group published news for 2024 q2
SEC form 8
2024-04-30 16:10 ET
MiMedx Group published news for 2024 q1
SEC form 8
2024-04-30 16:10 ET
MiMedx Group published news for 2024 q1
SEC form 8
2024-04-30 16:10 ET
MiMedx Group published news for 2024 q1
SEC form 8
2024-04-30 16:10 ET
MiMedx Group published news for 2024 q1
SEC form 10
2024-04-30 16:04 ET
MiMedx Group reported for 2024 q1
SEC form 10
2024-04-30 00:00 ET
MiMedx Group published news for 2024 q1
SEC form 8
2024-02-28 16:22 ET
MiMedx Group published news for 2023 q4
SEC form 8
2024-02-28 16:22 ET
MiMedx Group published news for 2023 q4
SEC form 8
2024-02-28 16:22 ET
MiMedx Group published news for 2023 q4
SEC form 10
2024-02-28 16:02 ET
MiMedx Group reported for 2023 q4
SEC form 10
2024-02-28 00:00 ET
MiMedx Group published news for 2023 q4
SEC form 10
2023-10-30 16:07 ET
MiMedx Group reported for 2023 q3
SEC form 8
2023-10-30 16:05 ET
MiMedx Group published news for 2023 q3
SEC form 10
2023-10-30 00:00 ET
MiMedx Group published news for 2023 q3
SEC form 10
2023-08-01 16:04 ET
MiMedx Group reported for 2023 q2
SEC form 6
2023-08-01 16:03 ET
MiMedx Group published news for 2023 q2
SEC form 8
2023-08-01 00:00 ET
MiMedx Group published news for 2023 q2
SEC form 6
2023-07-06 18:12 ET
MiMedx Group published news for 2023 q2
SEC form 6
2023-07-05 09:02 ET
MiMedx Group published news for 2023 q2
SEC form 6
2023-06-20 16:03 ET
MiMedx Group published news for 2023 q1
SEC form 6
2023-06-14 16:23 ET
MiMedx Group published news for 2023 q1
SEC form 10
2023-05-02 00:00 ET
MiMedx Group published news for 2023 q1
SEC form 8
2023-05-02 00:00 ET
MiMedx Group published news for 2023 q1
SEC form 6
2023-03-24 16:17 ET
MiMedx Group published news for 2022 q4
SEC form 6
2023-03-15 18:07 ET
MiMedx Group published news for 2022 q4
SEC form 6
2023-02-28 16:08 ET
MiMedx Group published news for 2022 q4
SEC form 10
2023-02-28 16:01 ET
MiMedx Group reported for 2022 q4
SEC form 10
2023-02-28 00:00 ET
MiMedx Group reported for 2022 q4
SEC form 8
2023-02-28 00:00 ET
MiMedx Group reported for 2022 q4
SEC form 6
2023-02-23 17:27 ET
MiMedx Group published news for 2022 q4
SEC form 6
2023-01-31 17:31 ET
MiMedx Group published news for 2022 q4
SEC form 6
2023-01-30 08:14 ET
MiMedx Group published news for 2022 q4
SEC form 6
2023-01-09 08:12 ET
MiMedx Group published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
MiMedx Group published news for 2022 q4
SEC form 6
2023-01-03 17:26 ET
MiMedx Group published news for 2022 q4
SEC form 6
2022-12-16 16:18 ET
MiMedx Group published news for 2022 q3
SEC form 6
2022-12-08 08:14 ET
MiMedx Group published news for 2022 q3
SEC form 6
2022-11-30 07:00 ET
MiMedx Group published news for 2022 q3
SEC form 6
2022-11-17 08:01 ET
MiMedx Group published news for 2022 q3
SEC form 6
2022-11-02 16:22 ET
MiMedx Group published news for 2022 q3
SEC form 10
2022-11-02 16:15 ET
MiMedx Group reported for 2022 q3
SEC form 10
2022-11-02 00:00 ET
MiMedx Group reported for 2022 q3
SEC form 8
2022-11-02 00:00 ET
MiMedx Group reported for 2022 q3
SEC form 6
2022-09-16 17:01 ET
MiMedx Group published news for 2022 q2
SEC form 6
2022-09-06 07:03 ET
MiMedx Group published news for 2022 q2
SEC form 6
2022-08-10 09:13 ET
MiMedx Group published news for 2022 q2
SEC form 6
2022-08-02 16:09 ET
MiMedx Group published news for 2022 q2
SEC form 10
2022-08-02 16:02 ET
MiMedx Group reported for 2022 q2
SEC form 10
2022-08-02 00:00 ET
MiMedx Group reported for 2022 q2
SEC form 8
2022-08-02 00:00 ET
MiMedx Group reported for 2022 q2
SEC form 6
2022-06-30 16:38 ET
MiMedx Group published news for 2022 q1
SEC form 6
2022-06-13 17:26 ET
MiMedx Group published news for 2022 q1
SEC form 6
2022-05-24 08:11 ET
MiMedx Group published news for 2022 q1
SEC form 6
2022-05-10 09:26 ET
MiMedx Group published news for 2022 q1
SEC form 6
2022-05-03 16:37 ET
MiMedx Group published news for 2022 q1
SEC form 10
2022-05-03 16:26 ET
MiMedx Group reported for 2022 q1
SEC form 10
2022-05-03 00:00 ET
MiMedx Group reported for 2022 q1
SEC form 8
2022-05-03 00:00 ET
MiMedx Group reported for 2022 q1
SEC form 6
2022-04-29 09:13 ET
MiMedx Group published news for 2022 q1
SEC form 6
2022-04-26 16:05 ET
MiMedx Group published news for 2022 q1
SEC form 6
2022-03-22 08:00 ET
MiMedx Group published news for 2021 q4
SEC form 10
2022-02-28 17:11 ET
MiMedx Group published news for 2021 q4
SEC form 6
2022-02-28 16:10 ET
MiMedx Group published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
MiMedx Group published news for 2021 q4
SEC form 8
2022-02-28 00:00 ET
MiMedx Group published news for 2021 q4
SEC form 6
2022-01-10 08:05 ET
MiMedx Group published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
MiMedx Group published news for 2021 q4
SEC form 6
2021-12-07 12:45 ET
MiMedx Group published news for 2021 q3
SEC form 6
2021-11-22 08:01 ET
MiMedx Group published news for 2021 q3
SEC form 6
2021-11-02 16:53 ET
MiMedx Group published news for 2021 q3
SEC form 10
2021-11-02 16:45 ET
MiMedx Group published news for 2021 q3
SEC form 10
2021-11-02 00:00 ET
MiMedx Group published news for 2021 q3
SEC form 8
2021-11-02 00:00 ET
MiMedx Group published news for 2021 q3
SEC form 6
2021-09-13 06:33 ET
MiMedx Group published news for 2021 q2
SEC form 6
2021-08-03 17:26 ET
MiMedx Group published news for 2021 q2
SEC form 10
2021-08-03 17:14 ET
MiMedx Group published news for 2021 q2
SEC form 10
2021-08-03 00:00 ET
MiMedx Group published news for 2021 q2
SEC form 8
2021-08-03 00:00 ET
MiMedx Group published news for 2021 q2
SEC form 6
2021-07-07 16:05 ET
MiMedx Group published news for 2021 q2
SEC form 6
2021-06-23 08:33 ET
MiMedx Group published news for 2021 q1
SEC form 8
2021-06-23 00:00 ET
MiMedx Group published news for 2021 q1
SEC form 6
2021-06-10 16:19 ET
MiMedx Group published news for 2021 q1
SEC form 6
2021-06-03 16:56 ET
MiMedx Group published news for 2021 q1
SEC form 6
2021-05-25 08:31 ET
MiMedx Group published news for 2021 q1
SEC form 6
2021-05-12 08:20 ET
MiMedx Group published news for 2021 q1
SEC form 6
2021-05-03 08:00 ET
MiMedx Group published news for 2021 q1
SEC form 6
2021-04-29 16:30 ET
MiMedx Group published news for 2021 q1
SEC form 6
2021-04-28 17:09 ET
MiMedx Group published news for 2021 q1
SEC form 10
2021-04-28 16:14 ET
MiMedx Group published news for 2021 q1
SEC form 10
2021-04-28 00:00 ET
MiMedx Group published news for 2021 q1
SEC form 8
2021-04-28 00:00 ET
MiMedx Group published news for 2021 q1
SEC form 6
2021-04-21 08:30 ET
MiMedx Group published news for 2021 q1
SEC form 6
2021-04-19 09:00 ET
MiMedx Group published news for 2021 q1
SEC form 6
2021-04-05 16:18 ET
MiMedx Group published news for 2021 q1
SEC form 6
2021-03-30 17:22 ET
MiMedx Group published news for 2020 q4
SEC form 6
2021-03-10 09:26 ET
MiMedx Group published news for 2020 q4
SEC form 6
2021-03-08 17:39 ET
MiMedx Group published news for 2020 q4
SEC form 10
2021-03-08 17:27 ET
MiMedx Group published news for 2020 q4
SEC form 6
2021-01-08 21:21 ET
MiMedx Group published news for 2020 q4
SEC form 6
2020-12-18 18:35 ET
MiMedx Group published news for 2020 q3
SEC form 6
2020-12-09 16:42 ET
MiMedx Group published news for 2020 q3
SEC form 6
2020-11-30 16:21 ET
MiMedx Group published news for 2020 q3
SEC form 6
2020-11-27 16:07 ET
MiMedx Group published news for 2020 q3
SEC form 6
2020-11-19 21:13 ET
MiMedx Group published news for 2020 q3
SEC form 6
2020-11-19 06:08 ET
MiMedx Group published news for 2020 q3
SEC form 6
2020-11-04 16:14 ET
MiMedx Group published news for 2020 q3
SEC form 10
2020-11-04 16:04 ET
MiMedx Group published news for 2020 q3
SEC form 6
2020-10-30 17:28 ET
MiMedx Group published news for 2020 q3
SEC form 6
2020-10-22 09:07 ET
MiMedx Group published news for 2020 q3
SEC form 6
2020-10-15 09:28 ET
MiMedx Group published news for 2020 q3
SEC form 6
2020-10-05 16:04 ET
MiMedx Group published news for 2020 q3
SEC form 6
2020-10-05 08:34 ET
MiMedx Group published news for 2020 q3